UCB, Inc. announces the publication of the Biologics Trend Report Sponsored By UCB, Volume 1. In this 56 page report, various industry stakeholders share their perspectives on the management and delivery of biologic treatments for Crohn's disease and rheumatoid arthritis. Managed care organizations, PBMs and specialty pharmacy providers, gastroenterologists, rheumatologists, and physicians’ reimbursement specialists participated in the research. They provided feedback on how they are managing these drugs in order to provide the best clinical outcomes while also achieving cost efficiencies and what some of the issues are that they must contend with throughout the process. The report is intended to help foster a collaborative approach in achieving practical, integrated solutions to the management of biologic therapies.

Click here to download a free pdf copy of this report.

©2012 Kikaku America International | Privacy Statement